Qube Research & Technologies (QRT)
ORKA

Qube Research & Technologies (QRT)’s Oruka Therapeutics ORKA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,026
Closed -$534K – 4070
2025
Q1 		$534K Sell
52,026
-100,056
-66% -$1.25M ﹤0.01% 2521
2024
Q4 		$2.95M Buy
152,082
+110,722
+268% +$2.7M ﹤0.01% 1724
2024
Q3 		$1.01M Buy
41,360
+41,356
+1,033,900% +$1.44M ﹤0.01% 2025
2024
Q2 		$192 Hold
4
– – ﹤0.01% 3397
2024
Q1 		$89 Hold
4
– – ﹤0.01% 4190
2023
Q4 		$85 Hold
4
– – ﹤0.01% 4035
2023
Q3 		$101 Buy
+4
New +$98 ﹤0.01% 3764

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ORKA Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Oruka Therapeutics (ORKA) in Q2 2025, closing a stake of 52,026 shares — an estimated $534K sold.

Qube Research & Technologies (QRT) first reported a position in ORKA in Q3 2023 and held it in 7 quarters. The position peaked at $2.95M in Q4 2024. 81 funds tracked by Wall St. Rank hold ORKA as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Oruka Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 52,026 Oruka Therapeutics shares in Q2 2025, an estimated $534K.
  • Qube Research & Technologies (QRT) first reported a position in Oruka Therapeutics in Q3 2023 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Oruka Therapeutics position peaked at $2.95M in Q4 2024.
  • 81 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.